Professor Anthony Costello, MD FRACS FRCSI(hon) MB BS
Position:
- Head, Department of Urology, The Royal Melbourne Hospital
- Executive Director, Australian Prostate Cancer Research Centre - Epworth
- Professorial Fellow, Department of Surgery, University of Melbourne
- Board Member, Australia Prostate Cancer Research Centre - Queensland
Websites:
Biography:
Professor Costello was the first urologist to use lasers to treat benign prostatic hyperplasia and has had international recognition in this field. He established an international urologic-oncology fellowship program commencing in 1991, where more than 30 fellows from all parts of the world have come to study postgraduate urologic-oncology surgery.
The only Australian member of the prestigious American Association of Genitourinary Surgeons, he is also an invited member of the International Advisory Board of the Cleveland Clinic Urological Department. In addition, Prof Costello is a national board member of the Australian Prostate Cancer Foundation.
In 2005, he developed a novel biological treatment of hormonal refractory prostate cancer, which is currently being trialed in phase I treatment for men with hormonal refractory prostate cancer and will soon be internationally trialed as a treatment for prostate cancer against conventional therapy.
In 2007, Prof Costello established the Victorian Prostate Cancer Research Collaborative, a network of research institutes interested in prostate cancer research housed at The Royal Melbourne Hospital.
Prof Costello has over 120 peer reviewed published articles and five book chapters in press and continues to innovate and lead initiatives in genito-urinary cancer research at The Royal Melbourne Hospital.
His current interest is in the development of drug treatment for prostate cancer and in clinical application of robotics in prostate cancer surgery. He heads the largest robotic surgery program in Australia and is one of four urologists invited to teach the technique of robotic prostatectomy for prostate cancer surgery at the American Association of Urological Surgery Annual General Meeting.
drug development, radical prostatectomy, tissue bank.
